<MedlineCitation Status="Completed">
<MedlineID>10011210</MedlineID>
<PMID>420740</PMID>
<DateCreated>
<Year>1979</Year>
<Month>05</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>1979</Year>
<Month>05</Month>
<Day>16</Day>
</DateCompleted>
<DateRevised>
<Year>2000</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article>
<Journal>
<ISSN>0007-1048</ISSN>
<JournalIssue>
<Volume>41</Volume>
<Issue>1</Issue>
<PubDate>
<Year>1979</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
</Journal>
<ArticleTitle>Serial changes in coagulation and viscosity during sickle-cell crisis.</ArticleTitle>
<Pagination>
<MedlinePgn>95-103</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Coagulation activity and whole-blood viscosity were measured in the steady state, and serially during painful crisis, in eight patients with sickle-cell anaemia. Platelet and coagulation activation occurred in the steady state and became more pronounced early in crisis. Whole-blood viscosity increased during crisis in parallel with plasma fibrinogen. Similar changes were found in a parallel study of 20 patients with localized bacterial or viral infection who did not have sickle-cell anaemia. Reports of platelet activation, hypercoagulability, and hyperviscosity during painful crisis therefore reflect secondary changes arising from vascular stasis, precipitating infection, and an acute-phase protein reaction. Although secondary, these changes may contribute to vascular occlusion by an additive effect in vessels already partially occluded by sickled cells.</AbstractText>
</Abstract>
<AuthorList>
<Author>
<LastName>Richardson</LastName>
<ForeName>S G</ForeName>
<Initials>SG</Initials>
</Author>
<Author>
<LastName>Matthews</LastName>
<ForeName>K B</ForeName>
<Initials>KB</Initials>
</Author>
<Author>
<LastName>Stuart</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author>
<LastName>Geddes</LastName>
<ForeName>A M</ForeName>
<Initials>AM</Initials>
</Author>
<Author>
<LastName>Wilcox</LastName>
<ForeName>R M</ForeName>
<Initials>RM</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>ENGLAND</Country>
<MedlineTA>Br J Haematol</MedlineTA>
<NlmUniqueID>0372544</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>9001-32-5</RegistryNumber>
<NameOfSubstance>Fibrinogen</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName>Adolescence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Anemia, Sickle Cell</DescriptorName>
<QualifierName MajorTopicYN="Y">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Blood Coagulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Blood Coagulation Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Blood Viscosity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Cold</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Fibrinogen</DescriptorName>
<QualifierName>analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Human</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Infection</DescriptorName>
<QualifierName>blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Middle Age</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
